论文部分内容阅读
目的:探讨腹腔镜肝切除治疗原发性肝癌的安全性与有效性。方法:回顾性分析2014年10月—2015年12月67例肝切除患者的临床资料,其中腹腔镜肝切除组37例,开腹肝切除组30例,比较分析两组患者术中、围手术期及随访数据资料。结果:与开腹组比较,腹腔镜组切口长度(5.65 cm vs.18.33 cm)、禁食时间(1.53 d vs.2.74 d)、止痛药用量(136.20 mg vs.290.75 mg)、术后住院时间(7.52 d vs.13.65 d)均有明显优势(均P<0.05);两组手术时间、术中失血量、围手术期肝功能指标,并发症发生率,术后6个月、1年生存率差异无统计学意义(均P>0.05)。结论:腹腔镜肝切除具有创伤小、疼痛轻、恢复快等优点,且安全可行,值得临床开展。
Objective: To investigate the safety and effectiveness of laparoscopic hepatectomy in the treatment of primary liver cancer. Methods: The clinical data of 67 patients with hepatectomy from October 2014 to December 2015 were retrospectively analyzed. Among them, 37 patients underwent laparoscopic liver resection and 30 patients underwent open hepatectomy. The operative and perioperative Period and follow-up data. Results: Compared with the open group, the length of laparoscopic incision (5.65 cm vs.18.33 cm), fasting time (1.53 d vs.2.74 d), analgesic dosage (136.20 mg vs.290.75 mg), postoperative hospital stay (7.52 d vs.13.65 d) (all P <0.05). The operation time, intraoperative blood loss, perioperative liver function index, incidence of complications, postoperative 6 months and 1 year There was no significant difference in survival rate (all P> 0.05). Conclusions: Laparoscopic hepatectomy has the advantages of less trauma, less pain and faster recovery, and is safe and feasible. It is worth to be carried out clinically.